Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1975 Feb;28(2):369–377.

Studies in vivo of cobra factor and murine C3.

M B Pepys
PMCID: PMC1445818  PMID: 804439

Abstract

The effect of the isolated C3-cleaving factor (CoF) of cobra venom on murine C3 in vivo and in vitro was studied. Optimal quantities of 100-200 units (0.5 minus 1.0 mg) of CoF per kg administered to mice by intraperitoneal injection in divided doses caused plasma C3 levels to fall to less than 5 per cent of normal from 1 to at least 4 days afterwards. Passive anti-CoF serum promptly abrogated the in vivo plasma C3 depletion, and under optimal conditions C3 levels reached 50 per cent of normal after approximately 15 hours. Injection of as little as 20 mug per mouse of CoF in saline induced a precipitating anti-CoF antibody response which prevented subsequent depletion of plasma C3 by CoF. The in vivo half-life of 125I-labelled CoF in normal mice estimated by whole body elimination and clearance from the blood was 24 hours. The presence in vivo of antibodies to CoF caused rapid clearance from the blood and elimination of 125I-labelled CoF, and also localization of some CoF in the spleen, liver and kidneys.

Full text

PDF
369

Images in this article

372FIG. 2
on p.372

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballow M., Cochrane C. G. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J Immunol. 1969 Nov;103(5):944–952. [PubMed] [Google Scholar]
  2. Charlesworth J. A., Williams D. G., Sherington E., Lachmann P. J., Peters D. K. Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J Clin Invest. 1974 Jun;53(6):1578–1587. doi: 10.1172/JCI107708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cochrane C. G., Müller-Eberhard H. J., Aikin B. S. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol. 1970 Jul;105(1):55–69. [PubMed] [Google Scholar]
  4. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  5. LAURELL C. B. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS. Anal Biochem. 1965 Feb;10:358–361. doi: 10.1016/0003-2697(65)90278-2. [DOI] [PubMed] [Google Scholar]
  6. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  7. MARDINEY M. R., Jr, MUELLER-EBERHARD H. J. MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION. J Immunol. 1965 Jun;94:877–882. [PubMed] [Google Scholar]
  8. Pepys M. B. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med. 1974 Jul 1;140(1):126–145. doi: 10.1084/jem.140.1.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pepys M. B. Role of complement in induction of the allergic response. Nat New Biol. 1972 May 31;237(74):157–159. doi: 10.1038/newbio237157a0. [DOI] [PubMed] [Google Scholar]
  10. Peters D. K., Martin A., Weinstein A., Cameron J. S., Barratt T. M., Ogg C. S., Lachmann P. J. Complement studies in membrano-proliferative glomerulonephritis. Clin Exp Immunol. 1972 Jul;11(3):311–320. [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES